Status:
ACTIVE_NOT_RECRUITING
Impact of Breast Cancer on Human Folliculogenesis
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Breast Cancer Female
Infertility, Female
Eligibility:
FEMALE
18-38 years
Brief Summary
Advances in cancer diagnosis and treatments have improved the 5-year survival rate for patients over the last decade. Nevertheless, cancer treatments frequently alter patient's fertility, thus comprom...
Detailed Description
Breast cancer patients (stratified into three molecular subgroups based on tumour hormonal status: HR+, HER2+, or triple-negative (TN)) and healthy oocyte donors (OD) are included in this study. Durin...
Eligibility Criteria
Inclusion
- Women above 18 years old and below 38 years old
- First hormonal stimulation cycle
- No dysovulation
- No cancer treatments prior fertility preservation (tumour resection, chemotherapy, radiotherapy)
- Women capable of giving written informed consent to participate in the research study
- Affiliated to social welfare service
Exclusion
- Women below 18 years old and above 38 years old
- Endocrine disease
- Endometriosis
- Any cancer treatments prior fertility preservation (tumour resection, chemotherapy, radiotherapy)
- Previous hormonal stimulation cycle of less than six months
Key Trial Info
Start Date :
January 11 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07148141
Start Date
January 11 2019
End Date
August 31 2025
Last Update
August 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, Auvergne Rhones-Alpes, France, 63000